Onconova Announces Results From Phase 3 ONTIME Trial of Rigosertib in Higher Risk Myelodysplastic Syndromes (MDS)
February 19, 2014 16:01 ET
|
Onconova Therapeutics
-Rigosertib vs. Best Supportive Care did not meet the primary endpoint of statistically significant improvement in median overall survival-
-Post-hoc analysis demonstrates statistically...
Onconova Therapeutics, Inc. to Present at 2014 Leerink Global Healthcare Conference
February 11, 2014 08:27 ET
|
Onconova Therapeutics
NEWTOWN, Pa., Feb. 11, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. to Present at the 16th Annual BIO CEO & Investor Conference
February 06, 2014 08:46 ET
|
Onconova Therapeutics
NEWTOWN, Pa., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. to Host Webcast Regarding Insights Into Rigosertib Mechanism of Action With Scientific Founder, Dr. E. Premkumar Reddy
January 17, 2014 10:33 ET
|
Onconova Therapeutics
NEWTOWN, Pa., Jan. 17, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference
January 06, 2014 09:42 ET
|
Onconova Therapeutics
NEWTOWN, Pa., Jan. 6, 2014 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Announces Results of Interim Analysis of Metastatic Pancreatic Cancer Study
December 17, 2013 16:45 ET
|
Onconova Therapeutics
NEWTOWN, Pa., Dec. 17, 2013 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics to Host Analyst Event in New York City on December 19th
December 13, 2013 11:13 ET
|
Onconova Therapeutics
NEWTOWN, Pa., Dec. 13, 2013 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Announces Presentation of Positive Data From Clinical Trials of Rigosertib in Myelodysplastic Syndromes (MDS) at the 2013 ASH Annual Meeting
December 09, 2013 07:00 ET
|
Onconova Therapeutics
NEWTOWN, Pa., Dec. 9, 2013 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. to Present at the 25th Annual Piper Jaffray Healthcare Conference
November 27, 2013 09:00 ET
|
Onconova Therapeutics
NEWTOWN, Pa., Nov. 27, 2013 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. Reports Third Quarter 2013 Financial and Operational Results
November 12, 2013 16:01 ET
|
Onconova Therapeutics
NEWTOWN, Pa., Nov. 12, 2013 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...